OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical guideline on obesity care in patients with gastrointestinal and liver diseases – Joint ESPEN/UEG guideline
Stephan C. Bischoff, Johann Ockenga, Ahad Eshraghian, et al.
Clinical Nutrition (2023) Vol. 42, Iss. 6, pp. 987-1024
Open Access | Times Cited: 12

Showing 12 citing articles:

EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Journal of Hepatology (2024) Vol. 81, Iss. 3, pp. 492-542
Closed Access | Times Cited: 254

EASL-EASD-EASO Clinical Practice Guidelines on the Management of Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Frank Tacke, Paul Horn, Vincent Wai‐Sun Wong, et al.
Obesity Facts (2024) Vol. 17, Iss. 4, pp. 374-444
Open Access | Times Cited: 51

Heavy arch: from inflammatory bowel diseases to metabolic disorders
Timon E. Adolph, Moritz Meyer, A Jukic, et al.
Gut (2024) Vol. 73, Iss. 8, pp. 1376-1387
Open Access | Times Cited: 14

Evaluation and Management of Nutritional Consequences of Chronic Liver Diseases
Silvia Espina, Diego Casas Deza, Vanesa Bernal Monterde, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3487-3487
Open Access | Times Cited: 21

Empagliflozin attenuates liver fibrosis in high‐fat diet/streptozotocin‐induced mice by modulating gut microbiota
Chuxin Huang, Jiali Qian, Ying Liu, et al.
Clinical and Experimental Pharmacology and Physiology (2024) Vol. 51, Iss. 3
Closed Access | Times Cited: 4

Emerging drugs for the treatment of sarcopenia in cirrhosis of the liver
Simone Di Cola, Saniya Khan, Lucia Lapenna, et al.
Expert Opinion on Emerging Drugs (2024) Vol. 29, Iss. 2, pp. 81-91
Open Access | Times Cited: 2

Show me the evidence to guide nutrition practice: Scoping review of macronutrient dietary treatments after metabolic and bariatric surgery
Julie Parrott, Sue Benson‐Davies, Mary O’Kane, et al.
Obesity Reviews (2024) Vol. 25, Iss. 12
Open Access | Times Cited: 1

Obesity management for the hepatologist—What to do, how to do it and why?
Kymberly D. Watt, Sonali Paul, Mohammad Qasim Khan, et al.
Hepatology (2023)
Closed Access | Times Cited: 2

Significant Published Articles in 2023 for Pharmacy Nutrition Support Practice
Roland N. Dickerson, Angela L. Bingham, Todd W. Canada, et al.
Hospital Pharmacy (2024) Vol. 59, Iss. 5, pp. 568-574
Open Access

Optimal Management of Obesity in Transplant Candidates and Recipients
Jenny Lam, Mohammad Qasim Khan, Kymberly D. Watt, et al.
Current Transplantation Reports (2024) Vol. 11, Iss. 2, pp. 84-94
Closed Access

Artificial intelligence–based skeletal muscle estimates and outcomes of EUS-guided treatment of pancreatic fluid collections
Mamoru Takenaka, Wataru Gonoi, Tatsuya Sato, et al.
iGIE (2024) Vol. 3, Iss. 3, pp. 382-392.e8
Closed Access

What Do We Know About the Nutritional Status of a Patient with Primary Biliary Cholangitis?
А. В. Тимощенко, E. V. Vinnitskaya, T.N. Kuzmina
Effective Pharmacotherapy (2023) Vol. 19, Iss. 43, pp. 54-63
Open Access

Page 1

Scroll to top